Log in to save to my catalogue

SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa

SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d47083157aa74d098d978a5ba9d51fe3

SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa

About this item

Full title

SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa

Publisher

United States: U.S. National Center for Infectious Diseases

Journal title

Emerging infectious diseases, 2022-05, Vol.28 (5), p.1055-1058

Language

English

Formats

Publication information

Publisher

United States: U.S. National Center for Infectious Diseases

More information

Scope and Contents

Contents

By November 2021, after the third wave of severe acute respiratory syndrome coronavirus 2 infections in South Africa, seroprevalence was 60% in a rural community and 70% in an urban community. High seroprevalence before the Omicron variant emerged may have contributed to reduced illness severity observed in the fourth wave.

Alternative Titles

Full title

SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d47083157aa74d098d978a5ba9d51fe3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d47083157aa74d098d978a5ba9d51fe3

Other Identifiers

ISSN

1080-6040

E-ISSN

1080-6059

DOI

10.3201/eid2805.220278

How to access this item